EVOK שווי כולל של נכסי החברה Evoke Pharma Inc.

The price history on the total assets chart for Evoke Pharma, Inc. (EVOK) is 14.91. Evoke Pharma, Inc. (EVOK) is promoting a highly specialized therapy for gastrointestinal organs, where cash flow relies on insurance reimbursements and physician recognition. Production is automated via robotic filling systems, which reduces personnel costs. Meanwhile, the high margins of the gastroparesis spray allow the company to lower unit logistics costs as sales grow.

For the fundamental screening of Evoke Pharma, Inc. (EVOK) assets, the scale of resources is critically important and is reverse-calculated via return on assets (ROA) to filter for sustainable issuers, while the company's total resources on the chart reflect a balance between minimizing bankruptcy risk and growth rates, which is particularly significant for a biopharmaceutical startup investing in the development of an innovative nasal drug delivery system for gastroparesis.